Carelabs Co

Carelabs Co EBITDA per Share

The EBITDA per Share of Carelabs Co (263700.KQ) as of Nov 3, 2026 is 1,872.01 KRW. In the previous year, EBITDA per Share was -1,216.26 KRW — a change of -253.92% (higher).

EBITDA per Share

1,872.01KRW

YoY

-253.92%

Last updated:

EBITDA per Share of Carelabs Co is 2025 1,872.01 KRW. EBITDA per Share of Carelabs Co was 2024 -1,216.26 KRW. It decreases by -253.92% higher compared to the previous year.

The Carelabs Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2016
171.33 KRW
Jan 1, 2017
539.62 KRW
Jan 1, 2018
508.78 KRW
Jan 1, 2019
353.69 KRW
Jan 1, 2020
655.34 KRW
Jan 1, 2021
614.61 KRW
Jan 1, 2023
-1,216.26 KRW
Jan 1, 2025
1,872.01 KRW
The Carelabs Co EBITDA per Share history
YEAREBITDA per ShareYoY
1,872.01KRW-253.92%
-1,216.26KRW-297.89%
614.61KRW-6.22%
655.34KRW+85.29%
353.69KRW-30.48%
508.78KRW-5.72%
539.62KRW+214.96%
171.33KRW+64.05%
104.44KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Carelabs Co Stock analysis

What does Carelabs Co do? Carelabs Co., Ltd. generates revenue through three business segments. The Healthcare Digital Marketing segment offers marketing planning, production, and agency services. The Healthcare Media Platform segment provides hospital pharmacy search services and community apps under the brands GOODOC and BABITALK. The Healthcare Solution segment sells CRM software, prescription security systems, and pharmacy billing programs. Domestic and overseas markets purchase these products and services, with GOODOC and BABITALK being key brand names in the media platform segment. The company's primary customers are healthcare institutions and businesses seeking digital marketing and media solutions. GOODOC and BABITALK serve as the main platforms for beauty care community apps and pharmacy search services. The Healthcare Solution segment targets pharmacies and hospitals needing CRM and billing systems. All products are distributed domestically and internationally without specifying additional market details. Carelabs Co., Ltd. focuses on delivering software and content services within the healthcare sector. The brand names GOODOC and BABITALK are central to the Healthcare Media Platform segment, while CRM software and pharmacy billing programs drive the Healthcare Solution segment. Domestic and overseas markets represent the key customer segments for all three business areas. Carelabs Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Carelabs Co stock

EBITDA per Share of Carelabs Co is 1,872.01 KRW in 2025.

EBITDA per Share of Carelabs Co changed from -1,216.26 KRW to 1,872.01 KRW, representing a -253.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Carelabs Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Carelabs Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Carelabs Co